Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06436560Not ApplicableEnrolling By Invitation

Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study

Role: collaborator

NCT06872307Not ApplicableRecruiting

Intervention to Enhance PrEP Persistence

Role: collaborator

NCT06062979Enrolling By Invitation

Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care

Role: lead

NCT04311554Unknown

Aging With Dignity, Health, Optimism and Community

Role: collaborator

All 4 trials loaded